Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Bupivacaine for Pain After THR
NCT03001453Phase 2Completed
- Sponsor
- American Hip Institute
- Start
- Apr 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by American Hip Institute. Primary endpoints: Patient Morphine Equivalent Consumption at 72 hours, Change in Patient-reported Visual Analog Scale (VAS) Pain Intensity Score at 72 hours and 3 more. Started Apr 2014; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03001453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001453.